Skip to search.
 FTSE 100 Up 0.66%
Streaming
Ticker Tape: On

More On ONXX

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Onyx Pharmaceuticals, Inc. (ONXX)

-NasdaqGS
124.70 30 Sep 21:00
Add to Portfolio
Prev Close:124.70
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:135.92
Beta:2.16
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:68.12 - 136.87
Volume:0
Avg Vol (3m):2,834,630
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ONXX 0.00%N/A
AVEO68.58m
MRK169.09b
NVS209.06b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Sep-13) :N/A
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback